Cancer de la prostate

Qu'est-ce que c'est?

Prostate cancer is cancer that begins in the prostate gland (which is present in people assigned male at birth unless surgically removed). Most prostate cancers are slow growing and diagnosed in those who are older than 65. When found early before the cancer has spread beyond the prostate, the five-year survival rate is close to 100%.

Early Detection = Better Outcomes®, so it’s important to get screened, reduce your risk, and talk with your health care provider about your health history.

Multi-ethnic group of middle aged men playing basketball.

Faites-vous examiner

Screening is done with a prostate-specific antigen (PSA) blood test. A digital rectal exam (DRE) may also be done as part of screening. If you have a prostate gland, follow these screening guidelines:*

*Source: American Cancer Society

Ages 45-69: If you are Black

If you are Black, begin screening with a PSA test at age 45. You should be screened every year until age 69. This applies regardless of whether or not you have a family history of prostate cancer.

Ages 45-69: If you have a significant family history

If you have a strong family history of prostate cancer, begin screening with a PSA test at age 45. You should be screened every year until age 69.

Having a strong family history means:

  • You have a close relative (parent, child or sibling) who had prostate cancer before age 65
  • You have more than one close relative (parent, child or sibling) who was diagnosed with prostate cancer at any age.

If you are not Black and have just one close relative (parent, child or sibling) who was diagnosed with prostate cancer at age 65 or older, you should get screened every two years from ages 45-69.

Ages 50-69: If you're at average risk

Start getting screened at age 50 if you are at average risk of prostate cancer. You should be screened with a PSA test every two years until age 69.

Ages 70-74: Individual decision

Continuing screening at ages 70-74 is an individual decision, as the balance of benefits and harms remains uncertain. Talk to your healthcare provider for help deciding if you should be screened.

Screening is not recommended for those ages 75 and older. Some people in this age group who are very healthy may want to continue screening; you should discuss this with a healthcare provider.

If you are age 80 or older, you should not get screened.

Additional screening: If you have an elevated PSA

If you have an elevated PSA level, you should undergo repeat PSA testing between two weeks and three months.

If you have a confirmed elevated PSA level, you can get testing with magnetic resonance imaging (MRI) and/or a validated biomarker test to help determine whether you need a prostate biopsy.

What is considered an elevated PSA level?

  • Ages 45-69: 3.0 ng/mL or higher
  • Ages 70-74: 6.5 ng/mL or higher

Couverture d'assurance

Under federal law, private insurers and Medicaid are required to cover services that have an “A” or “B” grade by the U.S. Preventive Services Task Force (USPSTF). Some insurers may choose to cover services for additional groups. Medicare coverage for preventive services is limited to tests for which Congress has explicitly authorized coverage.

Guidelines from the USPSTF give a “C” grade for PSA testing for men ages 55 to 69 and a “D” grade for men 70 and older. They advise a shared-decision making process between patient and provider. The American Cancer Society recommends beginning screening at age 45 or 50, depending on risk factors.

Always check with your insurance provider to find out if you’ll be covered for routine prostate cancer screening.

Test génétique

Genetic testing may be an option for those who want more information about their prostate cancer risk based on their family health history or race/ethnicity.

Apprendre encore plus

Connaissez votre risque

Si vous avez une prostate, vous courez un risque accru de cancer de la prostate si vous :

  • Sont âgés de 50 ans ou plus.
  • Are overweight or medically classified as obese.
  • Use tobacco products, including cigarettes, or used them in the past.
  • Sont noirs.
  • Avoir BRCA1 ou BRCA2 mutations ou syndrome de Lynch.
  • Have a personal or family history of prostate cancer.

Réduisez votre risque

Vous pouvez réduire votre risque de cancer de la prostate grâce à ces modifications des risques liés au mode de vie :

Icon illustration of a cigarette with smoke coming from its tip and a large X over it indicating no smoking.

Avoid all forms of tobacco.

An icon illustration showing three people being connected with lines to indicate a family tree.

Know your family health history.

A family history of prostate cancer may mean you need to get screened earlier or more frequently than those of average risk.

Icon illustration of a body scale.

Maintenez un poids santé.

Get screened for prostate cancer based on guidelines and your personal risk factors.

Icon illustration of a magnifying glass.

Get screened for prostate cancer based on guidelines and your personal risk factors.

Signes et symptômes

Il n’y a généralement aucun symptôme aux premiers stades du cancer de la prostate. Certains symptômes peuvent également être causés par d’autres problèmes de santé, notamment une hypertrophie de la prostate ou une hyperplasie bénigne de la prostate (HBP). Discutez avec votre fournisseur de soins de santé si vous ressentez :

  • Problèmes urinaires, tels que des difficultés à démarrer ou à arrêter le flux urinaire, un flux urinaire faible ou interrompu, ou une sensation de douleur ou de brûlure en urinant.
  • A need to urinate more frequently, particularly at night.
  • Du sang dans les urines.
  • Érection douloureuse ou difficile.
  • Douleur dans le bas du dos, le bassin ou le haut des cuisses.

Options de traitement

Le traitement dépend du type et du grade des cellules tumorales, du stade du cancer et de vos autres problèmes de santé.

Surveillance active

Certains cancers de la prostate évoluent très lentement et ne nécessitent pas de traitement immédiat. Dans ces cas, vous et votre fournisseur de soins de santé pouvez décider d’une « surveillance active » (parfois appelée « attente vigilante ») avec des suivis réguliers, généralement tous les trois à six mois. Cette option devrait être réévaluée, car votre état ou vos préoccupations peuvent changer.

Chirurgie

La chirurgie du cancer de la prostate comprend généralement l'ablation de la prostate (prostatectomie) ainsi que des vésicules séminales et parfois des ganglions lymphatiques environnants.

Radiation

Ce traitement utilise de fortes doses de rayonnement pour tuer les cellules cancéreuses et réduire les tumeurs. Il peut être utilisé seul ou en association avec un autre traitement avant ou après une intervention chirurgicale.

Thérapie hormonale

Ce traitement est utilisé pour bloquer les hormones qui provoquent la croissance des cellules, y compris les cellules cancéreuses. Il peut être utilisé seul ou en association avec un autre traitement avant ou après une intervention chirurgicale.

Chimiothérapie

La chimiothérapie utilise des médicaments pour tuer les cellules cancéreuses. Il est généralement utilisé pour traiter le cancer de la prostate plus avancé et peut être administré en association avec un traitement hormonal ou seul.

Immunothérapie

Ce type de traitement contre le cancer aide votre système immunitaire à mieux réagir au cancer pour détecter et détruire les cellules anormales. Il est généralement utilisé pour traiter le cancer de la prostate plus avancé.

Thérapie focale

This minimally invasive treatment uses methods like extreme cold or heat to destroy the abnormal cells when surgery or radiation is not possible.

Le dernier

Voir plus